AzTrials
AzTrials

Chronic Insomnia CharacterizedDREAMSNCT07513584

Dual-track Residential Exercise With AI and Monitoring for Sleep

A study testing Fit Mirror-Guided Home-Based Exercise Program in people with Chronic Insomnia Characterized and Difficulty Falling Asleep, run by National Sun Yat-sen University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Official record
Search all trials

Trial summary

As societies rapidly transition toward aging demographics, sleep issues among community-dwelling older adults have emerged as a critical concern affecting healthy aging and independent living. Current single-track exercise intervention models are often difficult to implement due to suboptimal adherence. Read more about this study

Who is it for?
Ages 60 years and older
What is being tested?
Fit Mirror-Guided Home-Based Exercise Program
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
No sites listed yet
Study dates
1 Aug 2026to 31 Jul 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age ≥ 60 years
  • Capable of independent mobility (without the use of assistive devices).4
  • Meeting one of the following sleep disturbance criteria:
  • Core symptoms of DSM-5 chronic insomnia (self-reported) for ≥ 3 months. Insomnia Severity Index (ISI) ≥ 15 (moderate-to-severe insomnia). Pittsburgh Sleep Quality Index (PSQI) > 5 (poor sleep quality).
  • Basic ability to use a tablet or smartphone (caregivers may assist with login, but exercise must be performed by the participant).
  • Mini-Cog score ≥ 3.
  • Consent to wear wearable devices and participate in data collection.

Who cannot join

  • Major cardiovascular events within the past 3 months (e.g., acute myocardial infarction, unstable angina), severe heart failure, or uncontrolled hypertension (e.g., SBP ≥ 180 or DBP ≥ 110 mmHg).
  • Severe osteoarticular or neuromuscular diseases that prevent the safe completion of exercise (e.g., recent hip fracture, severe Parkinsonian imbalance).
  • Severe psychiatric disorders or substance use disorders that may affect adherence.
  • Untreated moderate-to-severe obstructive sleep apnea (OSA) with extreme daytime sleepiness (the study will use objective measurements for preliminary screening).
  • Currently receiving structured psychotherapy for insomnia (e.g., CBT-I or BBTi) and not yet stabilized.
  • Severe visual or hearing impairment that prevents following voice or visual instructions.

About this study

Official title: Dual-track Residential Exercise With AI and Monitoring for Sleep in Older Adults With Chronic Insomnia (DREAMS Study)

As societies rapidly transition toward aging demographics, sleep issues among community-dwelling older adults have emerged as a critical concern affecting healthy aging and independent living. Current single-track exercise intervention models are often difficult to implement due to suboptimal adherence. Therefore, this study aims to utilize artificial intelligence technology combined with a dual-track residential exercise mode to improve sleep quality, thereby enhancing the self-care and independent living abilities of the elderly

Read the detailed description

The DREAMS Study addresses the critical public health challenge of chronic insomnia among community-dwelling older adults (aged ≥60), which substantially impacts healthy aging and independent living. Traditional exercise interventions often suffer from suboptimal adherence and rely on subjective self-reporting that fails to capture the physiological "mismatch" between perceived and actual sleep. To get around these problems, this study uses a home-based, closed-loop, dual-track exercise recommendation model that combines wearable ActiGraph monitoring with AI-driven skeletal recognition technology (iMirror). This adaptive framework differentiates between insomnia phenotypes: daytime moderate-intensity training (HIIT or resistance exercise) is prescribed to enhance sleep drive for those with difficulty falling asleep (DFA), while nighttime relaxation training (yoga or Pilates) targets reduced hyperarousal for those with difficulty maintaining sleep (DMS). By utilizing continuous objective data, the system creates a feedback loop that dynamically adjusts exercise prescriptions (frequency, intensity, and timing), reducing the need for on-site professional supervision and ensuring safe implementation within the participant's familiar home environment. Ultimately, the DREAMS Study establishes a scalable, data-driven model for precision health promotion to inform future policies on sleep health in aging populations.

Being tested
Fit Mirror-Guided Home-Based Exercise Program
Keywords
precision health promotion, insomnia phenotyping, adaptive feedback loop, wearable technology

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fit Mirror-Guided Home-Based Exercise ProgramDevice

    The DREAMS Study evaluates an AI-driven, home-based, dual-track exercise intervention for community-dwelling older adults (≥ 60) with chronic insomnia. Integrating FitMirror skeletal recognition for real-time guidance and ActiGraph wearable monitoring for continuous data collection, the system creates a closed-loop feedback mechanism to optimize sleep health. The intervention is tailored to insomnia phenotypes: daytime HIIT or resistance training is prescribed to enhance sleep drive (targeting sleep-onset difficulties), while nighttime yoga or Pilates targets reduced hyperarousal (targeting sleep-maintenance difficulties). Using a quasi-experimental design, the study measures improvements in multi-dimensional sleep health and functional fitness at baseline, post-intervention (12 weeks), and follow-up (24 weeks).

Study groups in NCT07513584
Study groupRoleWhat they receive
AI-Driven Dual-Track Residential Exercise and Physiological Monitoring ArmExperimentalParticipants (≥ 60) with chronic insomnia undergo a 12-week home exercise intervention followed by a 12-week follow-up. The system integrates FitMirror AI skeletal recognition for real-time guidance and ActiGraph wearable monitoring for continuous data collection. An adaptive closed-loop mechanism tailors exercise to specific insomnia phenotypes: daytime HIIT or resistance training is prescribed to enhance sleep drive for those with sleep-onset difficulties (DFA), while nighttime yoga or Pilates targets reduced hyperarousal for those with maintenance difficulties (DMS). Effectiveness is evaluated at baseline, 12 weeks, and 24 weeks using linear mixed-effects models to track improvements in multi-dimensional sleep health and functional fitness.
Receives: Device: Fit Mirror-Guided Home-Based Exercise Program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Multi-dimensional Sleep Health Assessment via Objective Actigraphy and Subjective Diaries

    This study evaluates sleep using Buysse's (2018) Multidimensional Sleep Health framework. To address reviewer concerns regarding distinct units, the following parameters are reported separately: 1) Sleep Efficiency (%) and Duration (min), objectively monitored by ActiGraph wGT3X-BT (7-14 days per stage). 2) Sleep Regularity (min), defined as the standard deviation of the weekly sleep midpoint. 3) Sleep Timing (clock time), representing the average weekly midpoint. 4) Subjective Quality and Daytime Alertness (1-5 scale), captured via daily diaries where lower scores indicate better health. Actigraphy data are processed at 30-second epochs using ActiLife v6.13.3. This dual-track approach monitors how daytime HIIT (building sleep drive) and nighttime relaxation (reducing hyperarousal) affect specific insomnia phenotypes, overcoming the "mismatch" between subjective and objective perception. All metrics are summarized as weekly means

    Measured: Assessments are conducted at three key intervals: Baseline (T0), immediately post-intervention (12 weeks, T1), and at a follow-up (24 weeks, T2).

  2. Multi-component Functional Physical Fitness Performance

    The specific components of the physical assessment include the 30-second chair stand test to evaluate lower body strength by counting full stands from a seated position, and the 30-second arm curl test to measure upper body strength using 5-pound weights for women or 8-pound weights for men. Flexibility is assessed through the chair sit-and-reach test for the lower body and the back scratch test for the upper body, with distances measured in centimeters to determine the range of motion in the limbs. Agility and dynamic balance are recorded using the 8-foot up-and-go test, which times how quickly a participant can rise from a chair, walk 2.44 meters around a marker, and return to a seated position. Cardiorespiratory endurance is measured using either the 2-minute knee-up test, which counts total repetitions of lifting the knees to a specified height, or the 6-minute walk test, which measures the total distance traveled in meters and can be used to estimate maximal aerobic capacity.

    Measured: Assessments are conducted at three key intervals: Baseline (T0), immediately post-intervention (12 weeks, T1), and at a follow-up (24 weeks, T2).

Secondary outcomes (2)
  1. Body Composition Analysis via Multi-Frequency Bioelectrical Impedance Analysis

    Measurements are conducted in the morning, 3 hours post-meal, after emptying the bladder and avoiding vigorous exercise to prevent electrolyte and water fluctuations. Participants stand barefoot on the Tanita MC-780MA Multi-frequency Segmental Body Composition Analyzer, holding hand electrodes with arms positioned away from the torso. This assessment provides comprehensive data on basal metabolism, visceral fat index, body water, and segmental fat/muscle mass. Critically, it analyzes the Skeletal Muscle Mass Index (SMI), a key indicator for sarcopenia.

    Measured: Assessments are conducted at three key intervals: Baseline (T0), immediately post-intervention (12 weeks, T1), and at a follow-up (24 weeks, T2).

  2. Self-Reported Demographic and Clinical Health Profile

    Participants self-complete a structured questionnaire covering demographic variables (gender, height, weight, education level) and clinical history, including comorbidities such as hypertension, diabetes, cardiovascular disease, COPD, asthma, cancer, sleep apnea, stroke, or brain injury. The profile also records the frequency of lifestyle habits (smoking, alcohol, and exercise categorized as none, weekly, monthly, or yearly) and any past diagnosis of psychiatric disorders. This data ensures proper screening and baseline characterization of the study population.

    Measured: Collected at Baseline (T0).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Apr 2026
  2. Study start1 Aug 2026 (estimated)
  3. Primary completion31 Jul 2027 (estimated)
  4. Study completion31 Jul 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Model description
The DREAMS Study addresses chronic insomnia in community-dwelling older adults (≥ 60) through an AI-driven, home-based, dual-track exercise model. Integrating continuous wearable monitoring (ActiGraph) with skeletal recognition technology (FitMirror), the system creates a closed-loop feedback mechanism to overcome subjective reporting biases and adherence barriers. Intervention is tailored to insomnia phenotypes: daytime HIIT or resistance training enhances sleep drive for those with sleep-onset difficulties (DFA), while nighttime yoga or Pilates reduces hyperarousal for those with sleep-maintenance difficulties (DMS). Using a quasi-experimental design with assessments at baseline, 12 weeks (post-intervention), and 24 weeks (follow-up), the study employs linear mixed-effects models to evaluate improvements in multi-dimensional sleep health and functional fitness.
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07513584
Sponsor's protocol ID
11501EC021
Acronym
DREAMS
Status last verified
Mar 2026
First submitted
22 Mar 2026
Last updated
7 Apr 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Fit Mirror-Guided Home-Based Exercise Program in people with Chronic Insomnia Characterized and Difficulty Falling Asleep, run by National Sun Yat-sen University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 7 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Multi-dimensional Sleep Health Assessment via Objective Actigraphy and Subjective Diaries (time frame: Assessments are conducted at three key intervals: Baseline (T0), immediately post-intervention (12 weeks, T1), and at a follow-up (24 weeks, T2).). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in